Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 9/20 | 0.62 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.58 |
| ▸ | RELA | Q04206 | 1/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.53 |
| ▸ | NQO2 | P16083 | 1/20 | 0.51 |
| ▸ | FBP1 | P09467 | 1/20 | 0.50 |
| ▸ | HTR2A | P28223 | 2/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16052791 | 0.82 | PTGS2 (0.64) | NFE2L2AKR1C3PTGS1PTGS2 | |
| SCHEMBL5698418 | 0.82 | PTGS2 (0.64) | NFE2L2AKR1C3PTGS1PTGS2 | |
| SCHEMBL17439304 | 0.82 | PTGS2 (0.64) | NFE2L2AKR1C3PTGS1PTGS2 | |
| SCHEMBL9849735 | 0.82 | NFE2L2 (0.91) | NFE2L2RELAPTGS1PTGS2NQO2 | |
| SCHEMBL7481828 | 0.80 | AKR1C3 (0.58) | NFE2L2AKR1C3RELAPTGS2FBP1 | |
| SCHEMBL13264524 | 0.80 | APP (0.57) | NFE2L2AKR1C3PTGS2MAOB | |
| SCHEMBL27722400 | 0.80 | PTGS2 (0.59) | AKR1C3PTGS2 | |
| SCHEMBL9720723 | 0.80 | MAOB (0.55) | AKR1C3PTGS1PTGS2MAOB | |
| SCHEMBL9720721 | 0.80 | MAOB (0.55) | AKR1C3PTGS1PTGS2MAOB | |
| SCHEMBL698584 | 0.78 | NFE2L2 (1.00) | NFE2L2RELAPTGS1PTGS2NQO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0772601-B1 | 4,5-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2002-09-18 | — | — | EP | disclosed |
| US-6426360-B1 | ANTIARTHRITIC AGENTS | G D SEARLE & CO. | 2002-07-30 | — | — | US | disclosed |
| EP-1211244-A2 | 4,5-substitued imidazolyl compounds for the treatment of inflammation | G.D. Searle & Co. (US) | 2002-06-05 | — | — | EP | disclosed |
| WO-1996003387-A1 | 4,5-SUBSTITUTED IMIDAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-02-08 | — | — | WO | disclosed |